Medtronic (MDT) Other financing activities (2014 - 2026)

Medtronic's Other financing activities history runs 13 years deep, the most recent figure standing at -$5.0 million for Q1 2026.

• In Q1 2026, Other financing activities fell 103.12% year-over-year to -$5.0 million; the TTM figure through Jan 2026 stood at -$220.0 million (down 260.58% YoY), while the FY2025 annual figure was -$184.0 million, down 6033.33% from the prior year.
• Other financing activities came in at -$5.0 million for Q1 2026 at Medtronic, roughly flat from -$5.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $273.0 million in Q3 2022 to a low of -$719.0 million in Q1 2023.
• A 5-year average of -$19.2 million and a median of -$5.0 million in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities surged 6925.0% in 2022 and plunged 11883.33% in 2023, its largest moves.
• Medtronic's Other financing activities stood at $170.0 million in 2022, then retreated by 5.29% to $161.0 million in 2023, then sank by 130.43% to -$49.0 million in 2024, then surged by 89.8% to -$5.0 million in 2025, then changed by 0.0% to -$5.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$5.0 million, -$5.0 million, and $70.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison